Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
February 24, 2025
A recent randomized clinical trial provides promising evidence that...
Read More
Population Study Reveals Most Effective Antipsychotic Strategies for First-Episode Schizophrenia
February 16, 2025
A recent population-based cohort study examined the effectiveness o...
Read More
Social Determinants of Health and Suicide-Related Outcomes
February 12, 2025
Over 700,000 deaths annually are attributable to suicide. While psy...
Read More
Associations Between Biomarkers of Inflammation and Depressive Symptoms
February 7, 2025
A recent study published in Translational Psychiatry has provided ...
Read More
Depressive Symptoms and Amyloid Pathology
February 1, 2025
A recent large-scale study examined the association between depress...
Read More
Label Update for Viloxazine ER: New Pharmacodynamic Data and Breastfeeding Info
January 27, 2025
The FDA has approved an update for the label for viloxazine ER to n...
Read More
APA Updates Guidance on Borderline Personality Disorder
January 15, 2025
The American Psychiatric Association (APA) recently released update...
Read More
Effectiveness of Antidepressant Treatments In TRD
January 10, 2025
A comprehensive network meta-analysis recently published offers new...
Read More
FDA Approves Tirzepatide for Adults with Obstructive Sleep Apnea and Obesity
December 21, 2024
The FDA has approved tirzepatide for adults with moderate-to-severe...
Read More
Brexpiprazole and Sertraline Combination Therapy Improves PTSD Symptoms
December 18, 2024
Results from a phase III clinical trial indicated that a combinati...
Read More
Antipsychotic Polypharmacy on the Rise
December 16, 2024
Antipsychotic polypharmacy remains a common practice despite eviden...
Read More
Prevalence of ADHD in Adulthood
December 5, 2024
Despite the widespread prevalence of ADHD in adulthood, many patien...
Read More